What role does regulatory approval play in nanotechnology setbacks?
Regulatory approval is crucial for the commercialization of nanotechnology-based products. However, the regulatory landscape for nanotechnology is still evolving, leading to uncertainties and delays. Regulatory bodies like the FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) require extensive data on safety and efficacy, which can be difficult to provide given the nascent state of many nanotechnologies.
